MedTrace Logo

Vasculera in Participants With Lipedema

NCT05616962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-12-12

Study results available
· View outcomes & findings →

Summary

This study is designed to gain preliminary information via a uniform protocol regarding the clinical effects of Vasculera in participants with lipedema and the possible role of the glycocalyx as a physiological target for Vasculera activity. It is anticipated that the results of this case study will inform the development of a formal randomized, double-blind, placebo controlled trial.

Conditions

  • Lipedema

Interventions

DIETARY_SUPPLEMENT

Diosmiplex

diosmin glycoside in combination with alkaline granules known as alka4-complex

Sponsors & Collaborators

  • Northeastern University

    collaborator OTHER

  • Primus Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Robert Levy, MD · Primus Pharmaceuticals

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-26
Primary Completion
2019-09-23
Completion
2019-09-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05616962 on ClinicalTrials.gov